SCHEMBL8200468

SCHEMBL8200468

COc1ccc(-c2ccc3nc(-c4ccc(C5=NCCN5)cc4)cn3c2)cc1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 8/20 0.70
NISCH Q9Y2I1 3/20 0.63
PTGIR P43119 1/20 0.55
APP P05067 1/20 0.53
KDM4E B2RXH2 3/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
PKM P14618 2/20 0.50
EPHX2 P34913 1/20 0.50
ALDH1A1 P00352 2/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
ALDH1A2 O94788 1/20 0.47
SLC2A1 P11166 1/20 0.46
TLR9 Q9NR96 2/20 0.46
TLR7 Q9NYK1 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8218770 0.88 NISCH (0.61) ALDH1A3NISCHPTGIRAPPKDM4E
SCHEMBL8194609 0.88 NISCH (0.61) ALDH1A3NISCHAPPKDM4ENPC1
Hydrochloric Acid SCHEMBL8202383 0.81 ALDH1A3 (0.46) ALDH1A3NISCHAPPKDM4ENPC1
SCHEMBL9575256 0.79 NISCH (1.00) NISCHPTGIRKDM4E
SCHEMBL8197701 0.79 ALDH1A3 (0.44) ALDH1A3NISCHAPPKDM4ENPC1
SCHEMBL13325773 0.79 ALDH1A3 (1.00) ALDH1A3APPKDM4ENPC1RAB9A
SCHEMBL31380867 0.77 ALDH1A3 (0.86) ALDH1A3APPKDM4ENPC1RAB9A
Hydrochloric Acid SCHEMBL8202952 0.74 NISCH (0.54) ALDH1A3NISCHALDH1A1ALDH1A2SLC2A1
SCHEMBL8208826 0.74 LMNA (0.48) ALDH1A3NISCHAPPKDM4ENPC1
SCHEMBL2932154 0.74 ALDH1A3 (0.79) ALDH1A3APPKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed